While the bear market might have convinced some investors that growth stocks are permanently out of fashion, you don't need to look very far to find a few companies that are bucking the trend by powering forward despite gloomy conditions. 

In fact, there are several biopharma businesses whose futures are bright enough to continue offering attractive returns even when the rest of the market is falling. Many are approachable with relatively small sums of money, like $1,000, thanks to the intensity with which they're expected to grow. Let's examine two candidates that are simmering with potential and ready for purchasing right now.

Image source: Getty Images.

Continue reading

Source Fool.com